Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China
· Delayed Price · Currency is CNY 5.55
+0.03 (0.54%)
Apr 29, 2026, 3:05 PM CST
SHE:002252 Revenue
Shanghai RAAS Blood Products had revenue of 1.51B CNY in the quarter ending March 31, 2026, a decrease of -24.75%. This brings the company's revenue in the last twelve months to 6.85B, down -15.68% year-over-year. In the year 2025, Shanghai RAAS Blood Products had annual revenue of 7.35B, down -10.13%.
Revenue (ttm)
6.85B
Revenue Growth
-15.68%
P/S Ratio
4.93
Revenue / Employee
2.19M
Employees
4,045
Market Cap
36.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.35B | -828.28M | -10.13% |
| Dec 31, 2024 | 8.18B | 212.50M | 2.67% |
| Dec 31, 2023 | 7.96B | 1.40B | 21.27% |
| Dec 31, 2022 | 6.57B | 2.28B | 53.16% |
| Dec 31, 2021 | 4.29B | 1.53B | 55.26% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Chongqing Zhifei Biological Products | 10.91B |
| Asymchem Laboratories (Tianjin) | 6.67B |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Beijing Tiantan Biological Products | 6.17B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.82B |
| Hualan Biological Engineering | 4.60B |